Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 99

Similar articles for PubMed (Select 24424460)

1.

Axl-targeted cancer imaging with humanized antibody h173.

Li D, Liu S, Liu R, Park R, Yu H, Krasnoperov V, Gill PS, Li Z, Shan H, Conti PS.

Mol Imaging Biol. 2014 Aug;16(4):511-8. doi: 10.1007/s11307-013-0714-z.

PMID:
24424460
2.

An HDAC-Targeted Imaging Probe LBH589-Cy5.5 for Tumor Detection and Therapy Evaluation.

Meng Q, Liu Z, Li F, Ma J, Wang H, Huan Y, Li Z.

Mol Pharm. 2015 Jun 16. [Epub ahead of print]

PMID:
26030093
3.

Molecular imaging of tumors with nanobodies and antibodies: Timing and dosage are crucial factors for improved in vivo detection.

Bannas P, Lenz A, Kunick V, Well L, Fumey W, Rissiek B, Haag F, Schmid J, Schütze K, Eichhoff A, Trepel M, Adam G, Ittrich H, Koch-Nolte F.

Contrast Media Mol Imaging. 2015 Apr 27. doi: 10.1002/cmmi.1637. [Epub ahead of print]

PMID:
25925493
4.

A near-infrared phthalocyanine dye-labeled agent for integrin αvβ6-targeted theranostics of pancreatic cancer.

Gao D, Gao L, Zhang C, Liu H, Jia B, Zhu Z, Wang F, Liu Z.

Biomaterials. 2015 Jun;53:229-38. doi: 10.1016/j.biomaterials.2015.02.093. Epub 2015 Mar 14.

PMID:
25890722
5.

[Preparation of magnetic near infrared fluorescent probe and targeted multimodal imaging of human mesenchymal stem cells in vitro].

Yan R, Qin J, Wang J, Liu J, Wu C, Ren L, Shan H.

Zhonghua Yi Xue Za Zhi. 2015 Jan 6;95(1):56-60. Chinese.

PMID:
25876812
6.

Validation of nanobody and antibody based in vivo tumor xenograft NIRF-imaging experiments in mice using ex vivo flow cytometry and microscopy.

Bannas P, Lenz A, Kunick V, Fumey W, Rissiek B, Schmid J, Haag F, Leingärtner A, Trepel M, Adam G, Koch-Nolte F.

J Vis Exp. 2015 Apr 6;(98):e52462. doi: 10.3791/52462.

7.

Molecular imaging of tumor-infiltrating macrophages in a preclinical mouse model of breast cancer.

Sun X, Gao D, Gao L, Zhang C, Yu X, Jia B, Wang F, Liu Z.

Theranostics. 2015 Feb 27;5(6):597-608. doi: 10.7150/thno.11546. eCollection 2015.

8.

Correction: Soluble AXL: a possible circulating biomarker for neurofibromatosis type 1 related tumor burden.

PLOS ONE Staff.

PLoS One. 2015 Mar 17;10(3):e0119975. doi: 10.1371/journal.pone.0119975. eCollection 2015. No abstract available.

9.

Dual-color labeled anti-mucin 1 antibody for imaging of ovarian cancer: A preliminary animal study.

Zhang Q, Wang F, Wu YS, Zhang KK, Lin Y, Zhu XQ, Lv JQ, Lu XS, Zhang XL, Hu Y, Huang YP.

Oncol Lett. 2015 Mar;9(3):1231-1235. Epub 2014 Dec 17.

10.

In vivo NIRF imaging-guided delivery of a novel NGR-VEGI fusion protein for targeting tumor vasculature.

Ma W, Li G, Wang J, Yang W, Zhang Y, Conti PS, Chen K.

Amino Acids. 2014 Dec;46(12):2721-32. doi: 10.1007/s00726-014-1828-6. Epub 2014 Sep 3.

PMID:
25182731
11.

AXL mediates resistance to cetuximab therapy.

Brand TM, Iida M, Stein AP, Corrigan KL, Braverman CM, Luthar N, Toulany M, Gill PS, Salgia R, Kimple RJ, Wheeler DL.

Cancer Res. 2014 Sep 15;74(18):5152-64. doi: 10.1158/0008-5472.CAN-14-0294. Epub 2014 Aug 18.

PMID:
25136066
12.

Design, synthesis, and validation of Axl-targeted monoclonal antibody probe for microPET imaging in human lung cancer xenograft.

Liu S, Li D, Guo J, Canale N, Li X, Liu R, Krasnoperov V, Gill PS, Conti PS, Shan H, Li Z.

Mol Pharm. 2014 Nov 3;11(11):3974-9. doi: 10.1021/mp500307t. Epub 2014 Jul 9.

13.

In vivo tumor vasculature targeted PET/NIRF imaging with TRC105(Fab)-conjugated, dual-labeled mesoporous silica nanoparticles.

Chen F, Nayak TR, Goel S, Valdovinos HF, Hong H, Theuer CP, Barnhart TE, Cai W.

Mol Pharm. 2014 Nov 3;11(11):4007-14. doi: 10.1021/mp500306k. Epub 2014 Jun 25.

14.

Optical imaging of articular cartilage degeneration using near-infrared dipicolylamine probes.

Hu X, Wang Q, Liu Y, Liu H, Qin C, Cheng K, Robinson W, Gray BD, Pak KY, Yu A, Cheng Z.

Biomaterials. 2014 Aug;35(26):7511-21. doi: 10.1016/j.biomaterials.2014.05.042. Epub 2014 Jun 7.

PMID:
24912814
15.

Activation of HER3 interferes with antitumor effects of Axl receptor tyrosine kinase inhibitors: suggestion of combination therapy.

Torka R, Pénzes K, Gusenbauer S, Baumann C, Szabadkai I, Őrfi L, Kéri G, Ullrich A.

Neoplasia. 2014 Apr;16(4):301-18. doi: 10.1016/j.neo.2014.03.009.

16.

Near-infrared fluorescence imaging of non-Hodgkin's lymphoma CD20 expression using Cy7-conjugated obinutuzumab.

Lin X, Zhu H, Luo Z, Hong Y, Zhang H, Liu X, Ding H, Tian H, Yang Z.

Mol Imaging Biol. 2014 Dec;16(6):877-87. doi: 10.1007/s11307-014-0742-3.

PMID:
24833041
17.

Axl-altered microRNAs regulate tumorigenicity and gefitinib resistance in lung cancer.

Wang Y, Xia H, Zhuang Z, Miao L, Chen X, Cai H.

Cell Death Dis. 2014 May 15;5:e1227. doi: 10.1038/cddis.2014.186.

18.

Detection of vascular endothelial growth factor in colon cancer xenografts using bevacizumab based near infrared fluorophore conjugate.

Paudyal B, Paudyal P, Shah D, Tominaga H, Tsushima Y, Endo K.

J Biomed Sci. 2014 Apr 29;21:35. doi: 10.1186/1423-0127-21-35.

19.

Activation of AXL and antitumor effects of a monoclonal antibody to AXL in lung adenocarcinoma.

Iida S, Miki Y, Suzuki T, Mori K, Saito M, Niikawa H, Kondo T, Yamada-Okabe H, Sasano H.

Anticancer Res. 2014 Apr;34(4):1821-7.

PMID:
24692715
20.

Near-infrared fluorescence imaging of CD13 receptor expression using a novel Cy5.5-labeled dimeric NGR peptide.

Li G, Xing Y, Wang J, Conti PS, Chen K.

Amino Acids. 2014 Jun;46(6):1547-56. doi: 10.1007/s00726-014-1727-x. Epub 2014 Mar 21.

PMID:
24652439
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk